Simpler Grants.gov #PAR-25-225

NIH IGNITE Grants for Neurotherapeutic Agent Characterization and Efficacy Studies

This opportunity from the National Institutes of Health (NIH) seeks applications for the IGNITE program focused on neurotherapeutic agent characterization and efficacy studies. - Government Buyer: - National Institutes of Health (NIH) - Extramural Research Programs in the Neurosciences and Neurological Disorders - Products/Services Requested: - Research services for pharmacodynamic, pharmacokinetic, and in vivo efficacy studies - Focus on small molecules, biologics, and biotechnology-derived products targeting neurological or neuromuscular disorders - OEMs and Vendors: - No specific OEMs or vendors are named; this is an investigator-driven research grant - Unique/Notable Requirements: - Projects must demonstrate sufficient biological activity for further development - Intended to advance candidates to meet entry criteria for the Blueprint Neurotherapeutics Network or similar translational programs - Wide eligibility: educational institutions, businesses, nonprofits, government entities, and others - No part numbers or purchase quantities specified, as this is a research grant, not a product procurement

Description

This funding opportunity provides grants to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agents have sufficient biological activity for further development to treat neurological or neuromuscular disorders under the NINDS mission. Eligible therapeutic agents include small molecules, biologics, or biotechnology-derived products. The grant aims to advance projects to meet entry criteria for the Blueprint Neurotherapeutics Network or other translational programs. The opportunity supports a wide range of applicants including educational institutions, businesses, nonprofits, and government entities.

View original listing